GNH USA

Europe — EMA

Immunine

GNH USA supplies Immunine (Human Coagulation Factor IX), a coagulation factor for hemophilia B treatment. Request a quote for global supply to hospitals.

Human Coagulation Factor Ix

Request sourcing

1
Pack/s

What is Human Coagulation Factor Ix?

Human Coagulation Factor IX, the active ingredient in Immunine, is a coagulation factor presented as a sterile intravenous solution. It replaces deficient factor IX to correct the intrinsic pathway of the coagulation cascade, providing clotting support for individuals with hemophilia B (factor IX deficiency).

GNH USA supplies Immunine as a licensed, GDP‑compliant international pharmaceutical supplier, serving hospitals, transplant centres, oncology centres, pharmacies and clinics worldwide with reliable access to this essential biologic.

What is Human Coagulation Factor Ix used for?

Immunine is used to manage disorders of the intrinsic coagulation pathway, specifically hemophilia B.

Hemophilia B (Factor IX deficiency): Provides factor IX replacement to achieve hemostasis. Surgical prophylaxis in hemophilia B patients: Maintains adequate clotting during operative procedures. Bleeding episodes in hemophilia B: Controls acute hemorrhage.

What are the side effects of Human Coagulation Factor Ix?

Common Side Effects: - Infusion‑related reactions (e.g., flushing, chills) - Headache - Fever - Nausea - Arthralgia - Mild hypertension

Serious or Rare Side Effects: - Development of inhibitory antibodies against factor IX - Anaphylactic or severe allergic reactions - Thromboembolic events - Transmission of viral pathogens - Renal dysfunction - Hemolysis

What precautions apply to Human Coagulation Factor Ix?

Immunine requires careful clinical monitoring and individualized dosing.

Dose adjustment: Tailor dosage based on factor IX activity levels and patient response. Monitoring: Regularly assess for inhibitor development and coagulation parameters. Allergy: Evaluate for hypersensitivity to plasma‑derived proteins before administration. Pregnancy and lactation: Use only if the potential benefit justifies the potential risk; data are limited. Concomitant anticoagulants: Use with caution and monitor bleeding risk. Store at 2-8°C: keep refrigerated, protect from light, do not freeze or shake.

What does Human Coagulation Factor Ix interact with?

Immunine may interact with other hemostatic agents and anticoagulants.

Major Interactions (Avoid): - Concurrent use of activated prothrombin complex concentrates: increased thrombosis risk. - High‑dose factor IX with antifibrinolytics: potential for excessive clot formation. - Live vaccines: may alter immune response.

Moderate Interactions (Monitor Closely): - Heparin: monitor anticoagulation parameters. - Antiplatelet agents: heightened bleeding risk. - Other clotting factor products: assess cumulative factor levels.

Frequently asked questions

What is Immunine used for?+
Immunine is indicated for the treatment and prevention of bleeding in patients with hemophilia B, a genetic deficiency of coagulation factor IX. It provides the missing factor to restore normal clotting function during routine care, surgical procedures, or acute bleeding episodes.
How does Human Coagulation Factor IX work?+
Human Coagulation Factor IX supplied by Immunine replaces the deficient protein in hemophilia B patients. Once infused, it participates in the intrinsic tenase complex, activating factor X to Xa, which then leads to thrombin generation and fibrin clot formation, correcting the coagulation defect.
What determines the dose of Immunine?+
The dose of Immunine is individualized by the prescribing clinician based on the patient’s baseline factor IX activity, the severity of bleeding, body weight, and the clinical situation (e.g., prophylaxis versus acute treatment). No fixed dosing regimen is provided in public information.
Is Immunine safe during pregnancy or breastfeeding?+
Safety data for Immunine in pregnancy and lactation are limited. It should only be used when the potential benefit to the mother outweighs any possible risk to the fetus or infant, and the decision should be made by a qualified healthcare professional.
How do I order Immunine from GNH USA?+
To order Immunine, submit an enquiry on the product page at gnh-usa.com, specifying the required quantity. GNH USA works with hospitals, pharmacies, and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details (including cold‑chain handling if needed), and import documentation.
How does Immunine compare with other factor IX products?+
Immunine belongs to the same therapeutic class as other factor IX concentrates, whether plasma‑derived or recombinant. All aim to restore factor IX activity, but differences may exist in manufacturing processes, viral inactivation methods, and immunogenicity profiles. Clinical choice depends on physician preference, patient history, and regulatory approvals.
How should Immunine be stored and handled?+
Immunine must be stored at 2‑8 °C in a refrigerator, protected from light. It should not be frozen or shaken. Before use, inspect the vial for particulate matter or discoloration and allow the solution to reach room temperature if required by the administration protocol.
How is Immunine administered?+
Immunine is given by intravenous infusion under the supervision of a qualified healthcare professional. The infusion rate and volume are determined by the prescribing clinician, who may adjust based on patient tolerance and factor IX activity levels measured during treatment.
What are the most serious risks associated with Immunine?+
The most serious risks include the development of inhibitory antibodies that neutralize factor IX activity, severe allergic or anaphylactic reactions, and rare thromboembolic events. Monitoring for these complications is essential, especially after repeated exposures.
Who should not use Immunine?+
Immunine is contraindicated in individuals with known hypersensitivity to human factor IX or any component of the formulation. Patients with a history of severe inhibitor development or uncontrolled thrombosis should also avoid its use unless specifically advised by a specialist.
Information provided on this page is for educational use by procurement and clinical professionals. Always consult a licensed healthcare provider for medical advice and prescribing decisions. GNH USA supplies this product subject to applicable regulatory and licensing requirements.
Send a sourcing enquiry for this product →

Product details

Drug
Human Coagulation Factor Ix
Route
Intravenous Use
Manufacturer
Baxalta Innovations Gmbh
Origin
EU

Related products

A

A

Liquid Extract From Viscum Album Subsp. Abietis Var Abies Alba (1:20), Extraction Solvents: Water Fo

Helixor Heilmittel Gmbh
EU
A

A

Liquid Extract From Viscum Album Subsp. Abietis Var Abies Alba (1:20), Extraction Solvents: Water Fo

Helixor Heilmittel Gmbh
EU
A

A

Liquid Extract From Viscum Album Subsp. Abietis Var Abies Alba (1:20), Extraction Solvents: Water Fo

Helixor Heilmittel Gmbh
EU
A

A

Liquid Extract From Viscum Album Subsp. Abietis Var Abies Alba (1:20), Extraction Solvents: Water Fo

Helixor Heilmittel Gmbh
EU